COMP <GO>
DRS vs CGNX // EV/EBITDA & P/E VALUATION
Leonardo DRS Inc. (NASDAQ) VS. Cognex Corporation (NASDAQ) • 15-METRIC TALLY: DRS 7
— CGNX 7
▲ EV/EBITDA & P/E VALUATION LEADER: DRS
LAST: $37.68 (-4.94%) • MKT CAP: $10.58B
valuation
23.2x
LAST: $56.15 (-4.78%) • MKT CAP: $9.92B
valuation
58.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DRS VS. CGNX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DRS | CGNX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.80% | 66.90% | -43.10 | CGNX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 8.90% | +0.30 | DRS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 23.2x | 58.1x | -34.90 | DRS | /valuation <GO> |
| Free Cash Flow Yield | 2.15% | 2.39% | -0.24 | CGNX | /fcf-yield <GO> |
| Operating Margin | 9.50% | 16.30% | -6.80 | CGNX | /operating-margins <GO> |
| Net Profit Margin | 7.60% | 11.50% | -3.90 | CGNX | /net-margins <GO> |
| Revenue Growth (YoY) | 12.80% | 8.70% | +4.10 | DRS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.55% | -0.55 | CGNX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.59 | 12.69 | -9.10 | CGNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | CGNX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.6 | 50.9 | +12.70 | DRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.88 | +0.01 | DRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 80.6x | -48.60 | DRS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.58B | $9.92B | $659.4M | DRS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DRS REV | CGNX REV | DRS GROSS % | CGNX GROSS % | DRS FCF | CGNX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.65B | $994.4M | 23.8% | 66.9% | $227.0M | $236.8M |
| FY 2024 | $3.23B | $914.5M | 22.8% | 68.4% | $186.0M | $134.0M |
| FY 2023 | $2.83B | $837.5M | — | — | $77.8M | $75.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DRS // BETA 0.89
CGNX // BETA 0.88